Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
On the evening of June 22, Tongrentang (sh600085, share price of RMB 51.17, market value of RMB 70.178 billion) announced that Tongrentang Technology (hk01666, share price of HK $6.02, market value of HK $7.71 billion), a holding subsidiary of the company, would transfer its 49% equity of Beijing Tongrentang second traditional Chinese medicine hospital Co., Ltd. (Tongrentang second traditional Chinese medicine hospital) Beijing Tongrentang South Third Ring Middle Road drugstore Co., Ltd. (South Third Ring Middle Road drugstore) sold 49% of its equity to the related party Beijing Tongrentang medical care industry Investment Group Co., Ltd. (Tongrentang medical care), with the transfer prices of RMB 42.0112 million and 19.3763 million respectively.
This text is a result of machine translation.
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Briefing Jun 28, 2022 10:08 AM
· Healthcare
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
In-depth
Healthcare
AstraZeneca in China: Opportunities and Challenges [1/2]
AstraZeneca is a British pharmaceutical company founded in 1999 that focuses on discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and biological medicals for cardiovascular, renal, metabolism, respiratory and immunology diseases.
Jul 05, 2022 03:21 PM
Briefing Jun 28, 2022 09:57 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Jun 28, 2022 09:56 AM
· Healthcare
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing Jun 28, 2022 09:54 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Jun 28, 2022 09:50 AM
· Healthcare
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Briefing Jun 28, 2022 09:37 AM
· Healthcare
Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Healthcare
AI-driven Pharmaceutical Company Phil Rivers Nets Hundreds of Mns of CNY in Series A Round
Phil Rivers, incubated by the Institute of Computing Technology of the Chinese Academy of Sciences, is a platform company that drives drug discovery with 'computational medicine'.
Yesterday 10:08 PM
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Healthcare
Precision Autoimmune Therapeutics Earned CNY 140 Mn in Angel Financing Round
Biotech firm Precision Autoimmune Therapeutics, specializing in the research and development of innovative drugs for autoimmune diseases, will focus on the precise therapies of autoimmune diseases.
Jul 06, 2022 09:53 PM
Healthcare
Anti-cancer Drugs Developer Affinity Completed Series A+ Round
Affinity, a biopharmaceutical company focusing on developing anti-cancer drugs, gained capital favor for its tumor microenvironment activated platform and opportunities it may bring to oncology treatment.
Jul 06, 2022 08:42 PM
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Jun 23, 2022 10:27 AM
· Healthcare
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Briefing Jun 23, 2022 10:24 AM
· Healthcare
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
See more
Read next
Insight
Technology
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「2/2」
Jul 06, 2022 02:24 PM
Insight
Technology
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「1/2」
Jul 06, 2022 12:06 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.